Aprotinin in aortocoronary bypass surgery: Increased risk of vein-graft occlusion and myocardial infarction? Supportive evidence from a retrospective study

Thrombosis and Haemostasis

Volumn 75, Issue 1, 1996, Pages 1-3

  Van Der Meer, J ^a   Hillege, H L ^a   Ascoop, C A P L ^b   Dunselman, P H J M ^c   Mulder, B J M ^d   Van Ommen, G V A ^e   Pfisterer, M ^f   Van Gilst, W H ^a   Lie, K I ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b ST ANTONIUS HOSPITAL   (Netherlands)

^c Ignatius Hospital   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^f UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; APROTININ; DIPYRIDAMOLE;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; BLEEDING DISORDER; BLOOD TRANSFUSION; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DEATH; FEMALE; GRAFT OCCLUSION; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK; THROMBOEMBOLISM; THROMBOSIS;

EID: 0030070570     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1650311     Document Type: Article

References (14)

1. Royston D, Bidstrup BP, Taylor KM, Sapsford RN. Effect of aprotinin on need for blood transfusion after repeat open-heart surgery. Lancet 1987; ii: 1289-91
2. Fraedrich G, Weber C, Bernard C, Hettwer A, Schlosser V. Reduction of blood transfusion requirement in open heart surgery by administration of high doses of aprotinin - preliminary results. Thorac Cardiovasc Surg 1989; 37: 89-91.
3. Dietrich W, Barankay A, Dilthey G, Henze R, Niekau E, Sebening F, Richter JA Reduction of homologous blood requirement in cardiac surgery by intraoperative aprotinin application - clinical experience in 152 cardiac surgical patients. Thorac Cardiovasc Surg 1989; 37: 92-8.
4. Bidstrup BP, Royston D, Sapsford RN, Taylor KM. Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol). J Thorac Cardiovasc Surg 1989; 97: 364-72.
5. Alajmo F, Calamai G, Perna AM, Melissano G, Pretelli P, Palmarini MF, Carbonetto F, Noferi D, Boddi V, Palminiello A, Vacari M. High-dose aprotinin: hemostatic effects in open heart operations. Ann Thorac Surg 1989, 48: 536-9.
6. Cosgrove DM, Heric B, Lytle BW, Taylor PC, Novoa R, Golding LAR, Stewart RW, McCarthy PM, Loop FD Aprotinin therapy for reoperative myocardial revascularization: a placebo-controlled study. Ann Thorac Surg 1992; 54: 1031-8.
7. Fuster V, Badimon L, Badimon JJ, Adams PC, Turitto V, Chesebro JH. Drugs interfering with platelet functions: mechanisms and clinical relevance. In: Thrombosis and Haemostasis 1987. Verstraete M, Vermylen J, Lijnen R, Arnout J, eds. Leuven. Leuven University Press 1987; 349-418.
8. Bidstrup BP, Underwood SR, Sapsford RN, Streets EM. Effect of aprotimn (Trasylol) on aorto-coronary bypass graft patency J Thorac Cardiovasc Surg 1993;105: 147-53.
9. Havel M, Grabenwöger F, Schneider J, Laufer G, Wollenek G, Owen A, Simon P, Teufelsbauer H, Wolner E. Aprotinin does not decrease early graft patency after coronary artery bypass grafting despite reducing postoperative bleeding and use of donated blood. J Thorac Cardiovasc Surg 1994; 107: 807-10.
10. Lemmer JH, Stanford W, Bonney SL, Breen JF, Chomka EV, Eldredge WJ, Holt WW, Karp RB, Laub GW, Lipton MJ, Schaff HV, Tatooles CJ, Rumberger JA. Aprotinin for coronary bypass operations: efficacy, safety, and influence on early saphenous vein graft patency. J Thorac Cardiovasc Surg 1994; 107: 543-53.
11. van der Meer J, Hillege HL, Kootstra GJ, Ascoop CAPL, Mulder BJM, Pfisterer M, van Gilst WH, Lie KI. Prevention of one-year vein-graft occlusion after aortocoronary-bypass surgery A comparison of low-dose aspirin, low-dose aspirin plus dipyridamole, and oral anticoagulants. Lancet 1993; 342: 257-64.
12. Blauhut B, Gross C, Necek S, Doran JE, Späth P, Lundsgaard-Hansen P Effects of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement, and renal function after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1991; 101: 958-67.
13. Samama ChM, Mazoyer E, Bruneval P, Ciostek P, Bonnin Ph, Bonneau M, Roussi J, Baillart O, Pignaud G, Viars P, Caen JP, Drouet LO. Aprotinin could promote arterial thrombosis in pigs: a prospective randomized, blind study. Thromb Haemost 1994; 71: 663-9.
14. van der Meer J, Hillege HL, van Gilst WH, Brutel de la Rivière A, Dunselman PHJM, Fidler V, Kootstra GJ, Mulder BJM, Pfisterer M, Lie KI A comparison of internal mammary artery and saphenous vein grafts after coronary artery bypass surgery: no difference in one year occlusion rates and clinical outcome. Circulation 1994; 90 2367-74